:: CLDF ::

Home | Contact Us | Bookmark

MASH

HCC

ALCOHOL LIVER DISEASE

PEDIATRIC LIVER DISEASE

Embassy of Education

Webcasts Abstract Library

Pediatric Liver Disease | Abstract Library

The summaries are free for public use. The Chronic Liver Disease Foundation will continue to add and archive summaries of articles deemed relevant to CLDF by the Board of Trustees and its Advisors

1.	Wilson disease in the USA: epidemiology and real-world patient characteristics based on a retrospective observational health claims study.
	BMJ Open.2024 Dec 22;14(12):e089032.doi:10.1136/bmjopen-2024-089032
	Fang, Shona (S);Strader, Carey (C);Costantino, Halley (H);Weiss, Karl Heinz (KH);Hedera, Peter (P);

2.	Higher Incidence of Diabetes in Asymptomatic Healthy Fatty Liver Patients of Bangladesh: Prompt Intervention can Avert Complications.
	Euroasian J Hepatogastroenterol.2024 Dec 27;14(2):172-175.doi:10.5005/jp-journals-10018-1444
	Gani, Abm Shakil (AS);Al Mahmood, Abdullah (A);Alam, Afm Shafiqul (AS);Rahman, Mizanur (M);Alam, Raqibul (R);Mahmud, Tasnim (T);

3.	Dihydroxyacetone phosphate is a novel predictor of hepatic fibrosis in Latino adolescents with obesity.
	J Pediatr Gastroenterol Nutr.2024 Nov 25;80(1):174-181.doi:10.1002/jpn3.12420
	Schenker, Rachel B (RB);Ramirez, Cuauhtemoc B (CB);Jang, Cholsoon (C);Allayee, Hooman (H);Zhao, Xueheng (X);Setchell, Kenneth D R (KDR);Kohli, Rohit (R);Goran, Michael I (MI);

4.	A comparative analysis in monitoring 24-hour urinary copper in wilson disease: sampling on or off treatment?
	Orphanet J Rare Dis.2025 Jan 21;20(1):33.doi:10.1186/s13023-025-03545-2
	Mohr, Isabelle (I);Lamade, Patrick (P);Weber, Christophe (C);Leidner, Viola (V);Köhrer, Sebastian (S);Olkus, Alexander (A);Lang, Matthias (M);Langel, Andrea (A);Dankert, Patrischia (P);Greibich, Melanie (M);Wolf, Silke (S);Zimmer, Holger (H);Michl, Patrick (P);Poujois, Aurélia (A);Weiss, Karl Heinz (KH);Merle, Uta (U);

5.	Prospective comparison of an 18-gauge versus 16-gauge needle for percutaneous liver core-needle biopsy in children.

	Jing, Haoyu (H);Xu, Ruifang (R);Qian, Linxue (L);Yi, Zhanxiong (Z);Shi, Xianquan (X);Li, Li (L);Sun, Liying (L);Liu, Ying (Y);He, Enhui (E);

6.	Clinical symptoms, biochemistry, and liver histology during the native liver period of progressive familial intrahepatic cholestasis type 2.

	Kondou, Hiroki (H);Nakano, Satoshi (S);Mizuno, Tadahaya (T);Bessho, Kazuhiko (K);Hasegawa, Yasuhiro (Y);Nakazawa, Atsuko (A);Tanikawa, Ken (K);Azuma, Yoshihiro (Y);Okamoto, Tatsuya (T);Inui, Ayano (A);Imagawa, Kazuo (K);Kasahara, Mureo (M);Zen, Yoh (Y);Suzuki, Mitsuyoshi (M);Hayashi, Hisamitsu (H);

7.	The epidemiological characteristics of liver disease in hospitalized children: a 10-year single-center retrospective study.

	Chen, Fan (F);Huang, Yuan (Y);Huang, Zhihua (Z);Fang, Feng (F);Zhou, Hua (H);Shu, Sainan (S);

8.	Correlating neighborhood-level deprivation and pediatric metabolic dysfunction-associated steatotic liver disease.

	Hickman, Nicole E (NE);Price, Mason (M);Crespo, Noe C (NC);Feldstein, Ariel E (AE);

9.	Development and validation of pFIB scores for exclusion of significant liver fibrosis in pediatric MASLD.

	Lefere, Sander (S);Mosca, Antonella (A);Hudert, Christian (C);Dupont, Ellen (E);Fitzpatrick, Emer (E);Kyrana, Eirini (E);Dhawan, Anil (A);Kalveram, Laura (L);Pietrobattista, Andrea (A);Geerts, Anja (A);De Bruyne, Ruth (R);

10.	Good long-term outcomes of primary sclerosing cholangitis in childhood.

	Jerregård Skarby, Anna (A);Casswall, Thomas (T);Bergquist, Annika (A);Lindström, Lina (L);

11.	Frailty in children with chronic liver disease: Prevalence and impact on outcomes.

	Yadav, Deepika (D);Sood, Vikrant (V);Lal, Bikrant Bihari (BB);Khanna, Rajeev (R);Benjamin, Jaya (J);Kumar, Rakesh (R);Baweja, Sukriti (S);Alam, Seema (S);

12.	Targeted and non-targeted proteomics to identify the urinary protein biomarkers for Wilson disease.

	Dong, Simin (S);Wang, Xixi (X);Zhou, Huiling (H);Xu, Huan (H);Su, Liqian (L);Xie, Linshen (L);Li, Yongxin (Y);

13.	Iron and Copper Liver Concentrations in Wilson Disease.

	Day, Patrick Lloyd (PL);Fyffe-Freil, Ria (R);Vanderboom, Patrick (P);Spears, Grant (G);Wangensteen, Kirk (K);Bornhorst, Joshua (J);Hassan, Sara (S);Jannetto, Paul J (PJ);

14.	Utilization of dupilumab in an immunocompromised patient with extensive allergic fungal rhinosinusitis unsuitable for surgical intervention: A case report.

	Alotaibi, Naif H (NH);Abaalkhail, Mashal (M);Almusa, Hala (H);Alshenaifi, Lama A (LA);Alomairin, Ahmed (A);

HEPATITIS

HBV
HCV
HDV

CLD HEALTH OUTCOMES

CIRRHOSIS

Cirrhosis
HE
HRS
Thrombocytopenia

MASH

Slide Library
Publications
Webcasts
Abstract Library Committee Members

CHOLESTATIC

PBC

HCC

Slide Library
Publications
Webcasts
Algorithm
Abstract Library Committee Members

ALCOHOL LIVER DISEASE

Recorded Educational Webinar

PEDIATRIC LIVER DISEASE

Webcasts
Slide Library
Abstract Library

About CLDF

Board of Trustees
Board of Advisors/Faculty
CLDF Committees
2025 GI Fellow Board of Advisors

Other Resources

Journal Abstracts

The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2025 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.

Subscribe